This T cell type has been shown to be enhanced in the peripheral blood of post-infection IBD [91] and it was shown that their inflammatory activity as measured by IL-17 and IL-22 production, can be modified by the gut microbiota [36]. Here, IL17A is linked to inflammatory bowel disease.